Biological
Immunotherapy Regimen MKC-1106-MT clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2002
How studies write it
Studies that test it under each name
Name
- MKC1106-MT
- 2
Studies by the year they started
3 studies that test it; most in 2002 (1)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2008 | 1 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses Immunotherapy Regimen MKC-1106-MT is read from its arms, and is right about nine times in ten.
Testing it · 3
- Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With MelanomaTerminatedPhase 2Mannkind CorporationNCT01026051Written as MKC1106-MT
- Vaccine Therapy in Treating Patients With Stage IV MelanomaCompletedPhase 1/2Mannkind CorporationNCT00033228Written as MKC1106-MT
- Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma.CompletedPhase 1Mannkind CorporationNCT00688090Written as Biological: MKC1106-MT